Our findings demonstrate that elevated preoperative serum levels of IL‐6 and GDF‐15 are closely associated with the presence of sarcopenia, adverse pathological features and diminished survival outcomes in patients undergoing RC for BC. This evidence concerns the gene GDF15 and breast cancer.